sulfasalazine has been researched along with Enteropathy, Exudative in 3 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
EWE, K | 2 |
Winney, RJ | 1 |
Gilmour, HM | 1 |
Matthews, JD | 1 |
Karbach, U | 1 |
Dehos, H | 1 |
3 other studies available for sulfasalazine and Enteropathy, Exudative
Article | Year |
---|---|
[TREATMENT OF EXUDATIVE ENTEROPATHIES].
Topics: Drug Therapy; Gastrointestinal Diseases; Humans; Hypoproteinemia; Prednisone; Protein-Losing Enterop | 1965 |
Prednisolone in giant hypertrophic gastritis (Menetrier's disease).
Topics: Aged; Bronchitis; Colitis, Ulcerative; Edema; Gastritis; Humans; Hypertrophy; Male; Prednisolone; Pr | 1976 |
Antiinflammatory treatment and intestinal alpha 1-antitrypsin clearance in active Crohn's disease.
Topics: Adolescent; Adult; alpha 1-Antitrypsin; Anti-Inflammatory Agents; Crohn Disease; Feces; Female; Huma | 1985 |